[Real-world data of tenofovir amibufenamide therapy for treatment-naïve patients with chronic hepatitis B].

Authors

Institutions

Publication Details

Journal
PubMed
Published
2024-11-30
DOI
https://doi.org/10.3760/cma.j.cn501113-20240831-00453
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[Real-world data of tenofovir amibufenamide therapy for treatment-naïve patients with chronic hepatitis B].

Bo Feng, J R Zheng, Y D Xie
2 links
PubMed
Hepatitis B Virus Studies
article

[Real-world data of tenofovir amibufenamide therapy for treatment-naïve patients with chronic hepatitis B].

Bo Feng, J R Zheng, Y D Xie
article en

Abstract

No abstract available for this paper.
PubMedVol. 32(S1)
Peking University (CN), Peking University People's Hospital (CN)
Good health and well-being
Openalex Percentile: Top 62%
Hepatitis B Virus Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

[Real-world data of tenofovir amibufenamide therapy for treatment-naïve patients with chronic hepatitis B]. — Bo Feng, J R Zheng, et al. · PubMed (2024) | TGRS Research Map | TGRS